Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Expert Opinion on Drug Safety
|
October 16, 2024
Adverse reaction of specific acute kidney injury caused by atorvastatin: an actual study based on the database of the US FDA adverse event reporting system
Dongqiang Luo, Manting Liu, Zhenye Chen, et al.
Expert Opinion on Drug Safety
|
April 8, 2025
The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer
DongQiang Luo, Jiyuan Zheng, Bingshuo Liu, et al.
Biomolecules
|
February 25, 2023
HAMP as a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma
Guoming Chen, Cheng Zhang, Danyun Li, et al.
Scientific Reports
|
May 6, 2025
Disproportionality analysis of drug-induced erectile dysfunction using FAERS database
Xiaona Tian, Dongqiang Luo, Wenling Zeng, et al.
Expert Opinion on Drug Safety
|
October 25, 2024
Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
Shulan Huang, Hanlin Dong, Dongqiang Luo, et al.
European Journal of Ophthalmology
|
April 3, 2018
Implanting a posterior chamber phakic intraocular lens in highly myopic eyes with peripheral primary iris and ciliary body cysts
Jing Zhao, Dongqiang Luo, Yong Sun, et al.
Medicine
|
July 19, 2024
Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database
Bohui Zheng, Manting Liu, Dandan Dai, et al.
Scientific Reports
|
February 24, 2024
Biomarker screening using integrated bioinformatics for the development of "normal-impaired glucose intolerance-type 2 diabetes mellitus"
Dongqiang Luo, Xiaolu Gao, Xianqiong Zhu, et al.
Expert Opinion on Drug Safety
|
June 30, 2025
Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance
Yi Zeng, Jiazhen Jiang, Dongqiang Luo, et al.
Frontiers in Pharmacology
|
February 10, 2025
Shengxue Busui Decoction activates the PI3K/Akt and VEGF pathways, enhancing vascular function and inhibiting osteocyte apoptosis to combat steroid-induced femoral head necrosis
Manting Liu, Jiexiang Ye, Runtian Wu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Expert Opinion on Drug Safety
|
October 16, 2024
Adverse reaction of specific acute kidney injury caused by atorvastatin: an actual study based on the database of the US FDA adverse event reporting system
Dongqiang Luo, Manting Liu, Zhenye Chen, et al.
Expert Opinion on Drug Safety
|
April 8, 2025
The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer
DongQiang Luo, Jiyuan Zheng, Bingshuo Liu, et al.
Biomolecules
|
February 25, 2023
HAMP as a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma
Guoming Chen, Cheng Zhang, Danyun Li, et al.
Scientific Reports
|
May 6, 2025
Disproportionality analysis of drug-induced erectile dysfunction using FAERS database
Xiaona Tian, Dongqiang Luo, Wenling Zeng, et al.
Expert Opinion on Drug Safety
|
October 25, 2024
Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
Shulan Huang, Hanlin Dong, Dongqiang Luo, et al.
European Journal of Ophthalmology
|
April 3, 2018
Implanting a posterior chamber phakic intraocular lens in highly myopic eyes with peripheral primary iris and ciliary body cysts
Jing Zhao, Dongqiang Luo, Yong Sun, et al.
Medicine
|
July 19, 2024
Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database
Bohui Zheng, Manting Liu, Dandan Dai, et al.
Scientific Reports
|
February 24, 2024
Biomarker screening using integrated bioinformatics for the development of "normal-impaired glucose intolerance-type 2 diabetes mellitus"
Dongqiang Luo, Xiaolu Gao, Xianqiong Zhu, et al.
Expert Opinion on Drug Safety
|
June 30, 2025
Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance
Yi Zeng, Jiazhen Jiang, Dongqiang Luo, et al.
Frontiers in Pharmacology
|
February 10, 2025
Shengxue Busui Decoction activates the PI3K/Akt and VEGF pathways, enhancing vascular function and inhibiting osteocyte apoptosis to combat steroid-induced femoral head necrosis
Manting Liu, Jiexiang Ye, Runtian Wu, et al.
Page
of 2